Detalhe da pesquisa
1.
Buruli-RifDACC: Evaluation of the efficacy and cost-effectiveness of high-dose versus standard-dose rifampicin on outcomes in Mycobacteriumulcerans disease, a protocol for a randomised controlled trial in Ghana.
NIHR Open Res
; 2: 59, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36825217
2.
Challenges associated with the treatment of Buruli ulcer.
J Leukoc Biol
; 105(2): 233-242, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30168876
3.
Challenges Associated with Management of Buruli Ulcer/Human Immunodeficiency Virus Coinfection in a Treatment Center in Ghana: A Case Series Study.
Am J Trop Med Hyg
; 93(2): 216-23, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26055745